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Abstract

In the current study, Raman spectroscopy is employed for the identification of the biochemical
changes taking place during the development of Hepatitis C. The Raman spectral data acquired
from the human blood plasma samples of infected and healthy individuals is analysed by
Principal Components Analysis and the Raman spectral markers of the Hepatitis C Virus (HCV)
infection are identified. Spectral changes include those associated with nucleic acidsat720 cm-1,
1077 cm-1 1678 (C=O stretching mode of dGTP of RNA), 1778 cm-1 (RNA), with proteins at
1641 cm-1(amide-I), 1721 cm-1(C=C stretching of proteins) and lipids at 1738 cm-1(C=O of ester
group in lipids). These differences in Raman spectral features of blood plasma samples of the
patients and healthy volunteers can be associated with the development of the biochemical
changes during HCV infection.
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Introduction:
Hepatitis C is caused by the infection of a virus and almost 3% of the world and 4.8 % Pakistani
population is affected by this disease (Shepard, Finelli et al. 2005; Lavanchy 2009; Ford, Kirby
et al. 2012). Currently available screening techniques, like Enzyme Linked Immunosorbent
Assay (ELISA), involve the detection of the antibodies and pathogens in the blood of the patients
infected by Hepatitis C virus (HCV) (Kesli, Polat et al. 2011). Although, ELISA is very
commonly employed, observation of the false positive and false negative results indicates
difficulties in blood screening (Gretch 1997; Martin, Fabrizi et al. 1998; Schiff, de Medina et al.
1998).
Polymerase Chain Reaction (PCR) is currently considered as the gold standard technique for the
direct detection of the HCV RNA, the most reliable disease marker, in blood serum or plasma
(Raeymaekers 1993; Pawlotsky 2003).To achieve accurate results from this method, the reagents
and the instrumentation employed must be of high quality and sensitivity, respectively. In this
regard, it is important to mention that PCR based methods are considered more reliable than
ELISA based methods (Enomoto, Nishiguchi et al. 2001; Swellam, Mahmoud et al. 2011), but
the former technique is time consuming, less commonly available, laborious and expensive. This
demands the development of more reliable, rapid, biochemical label free and automated
diagnosis method which may be helpful for effective disease management.
Raman spectroscopy has been used for determining the biochemical changes in the biomacromolecules of cells and tissues, including lipids, proteins and DNA, simultaneously
(Nawaz, Bonnier et al. 2010; Nawaz, Bonnier et al. 2011; Nawaz, Garcia et al. 2013). Moreover,
the technique has been employed for the analysis of the body fluids, like blood plasma/serum and
urine, for the diagnosis of the diseases (Neugebauer, Trenkmann et al. 2014; Pachaiappan,

Prakasarao et al. 2017; Pappu, Prakasarao et al. 2017). The potential of Raman spectroscopy for
the diagnosis of diseases which are caused by viral infections, such as dengue (Saleem, Bilal et
al. 2013) and HPV (Ostrowska, Malkin et al. 2010; Ostrowska, Garcia et al. 2011)has also been
demonstrated.
Although the diagnosis of HCV infection in blood serum/plasma samples from infected patients
by employing Raman spectroscopy has been reported, these studies used Principal Component
Analysis (PCA) for the comparison of normal versus HCV positive samples (Saade, Pacheco et
al. 2008) and a Partial Least Squares Regression (PLSR) model for the prediction of the viral
load (Nawaz, Rashid et al. 2017). In the present study, serologically characterised HCV positive
blood plasma samples are divided into three different groups, for the purpose of comparison,
namely low, medium and high viral load samples, and their Raman spectral data is compared
with that of control/healthy samples by using PCA of these three degrees of infection of disease.
The analysis identifies specific spectral markers which may be associated with the presence, as
well as degree of infection.
Materials and methods
Sample preparation
Blood plasma samples from 10 healthy/control and 11 Hepatitis C patients with different viral
load values, as described in Table 1, were collected from Allied Hospital, Faisalabad, Pakistan.
These patients were diagnosed as infected with HCV by the Polymerase Chain Reaction (PCR)
technique, and classified into three groups on the basis of viral load values, currently a gold
standard for the diagnosis of Hepatitis, which quantified the HCV loads in the patient samples.
Raman spectral acquisition
A 20 μl drop of each plasma sample was placed on an aluminium slide at room temperature and
Raman spectra were acquired before the plasma sample had dried. The process of placing the

20μl drop on the aluminium slide was repeated 3 times by employing a clean aluminium slide
each time for acquiring 20-25 spectra in total from each sample.
Raman spectral acquisition from all of the 10 healthy/control and 11 HCV infected blood plasma
samples was performed using a Raman spectrometer (Peak Seeker Pro-785; Agiltron, USA). The
Peak Seeker Pro-785 utilizes a 785nm diode laser as the excitation source, delivering a laser
power of ~60 mW at the sample. The laser was delivered to the sample through a 10× objective.
The acquisition of the Raman spectra for all the samples was executed from 600 to 1800 cm-1and
20–25 Raman spectra per sample were acquired with an acquisition time of 30 seconds.
Data pre-processing
All data processing of the Raman spectra was performed using MatLab 7.8 and established
protocols (Nawaz, Bonnier et al. 2010). Data pre-processing included baseline correction,
smoothing, vector normalisation, and substrate removal. All spectra, including substrate
backgrounds, were vector normalised and smoothed using a Savitzky–Golay smoothing method
(order 3, 17 point window). A rubber band correction for baseline removal for all the spectra was
carried out and the substrate spectra were subtracted from each spectrum.
Data analysis
The Raman spectral features were analysed by comparing the mean Raman spectra of HCV
infected blood plasma samples with healthy ones. The Raman peak assignments were taken from
the literature, as detailed in Table 2. PCA was used to differentiate groups of the spectral data
acquired for the different blood plasma samples determined by PCR to be positive for HCV
infection, and to identify their characteristic spectroscopic signatures. PCA is a mathematical
procedure involving the transformation of possibly correlated variables into a smaller number of
uncorrelated variables, known as principal components (PC), basically to reduce the
dimensionality of the data whilst maintaining their variability. The first principal component
accounts for the dominant source of variability in the data, and each successive principal
component accounts for the next highest source of the remaining variability. The loadings of the
PC can be understood as the orthogonal dimensions of biochemical differences which facilitate
separation of different groups of spectra of Raman data along their variability as each spectrum
scores along these dimensions.

Sample name

Viral load value

Category

HCV-1

20,718

Low

HCV-2

120,533

Low

HCV-3

132,152

Low

HCV-4

189,531

Low

HCV-5

387,823

Medium

HCV-6

410,358

Medium

HCV-7

442,365

Medium

HCV-8

846,668

High

HCV-9

873,417

High

HCV-10

907,874

High

HCV-11

1,718,359

High

Table 1: Viral load values of the HCV samples.

Wave numbers (cm-1)

Peak assignments

References

616

C-C twisting (protein)

(Chan,
Taylor et al.
2006)

630

n(C-S) gauche (aminoacid
methionine)

(Shetty,
Kendall et
al. 2006)

651

n(C-S) gauche (aminoacid
methionine)

(Shetty,
Kendall et
al. 2006)

674

Ring breathing modes in the DNA
bases G/T

(Chan,
Taylor et al.

2006)
703

Cholesterol, cholesterol ester

(Krafft,
Neudert et
al. 2005)

720

Adenine

(Jess, Smith
et al. 2007)

727

Adenine base/DNA

(Kline and
Treado
1997)

751

Symmetric breathing of tryptophan
(protein assignment)

(Stone,
Kendall et
al. 2002;
Huang,
McWilliams
et al. 2003;
Cheng, Liu
et al. 2005)

761

Tryptophan, d (ring)

(Shetty,
Kendall et
al. 2006)

737-73

Lactic acid , DNA, Tryptophan, d
(ring)

(Binoy,
Abraham et
al. 2004;
Shetty,
Kendall et
al. 2006)

785/788

Phosphodiester bands in DNA/RNA

(Notingher,
Green et al.
2004)

810/815

Proline, hydroxyproline, tyrosine,
RNA

(Cheng, Liu
et al. 2005)

Proline

(Cheng, Liu
et al. 2005)

830

850

Most probably due to single bond
stretching
vibrations for the amino acids and
valine and
polysaccharides

(Cheng, Liu
et al. 2005)

857

Tyrosine, collagen

(Stone,
Kendall et
al. 2004)

880

Tryptophan, d(ring)

(Shetty,
Kendall et
al. 2006)

900

Monosaccharides (b-glucose), (C-OC) skeletal
Mode

(Shetty,
Kendall et
al. 2006)

911

Glucose

(Krafft,
Neudert et
al. 2005)

922

Collagen

(Frank,
McCreery et
al. 1995)

934

C-C stretching/protein assignment

(Stone,
Kendall et
al. 2004)

951

ns(CH3) of proteins

(Lakshmi,
Kartha et al.
2002)

958

Hydroxyapatite, carotenoid,
cholesterol

(Stone,
Kendall et
al. 2004)

991

C-O ribose, C-C

(Dukor
2002)

1005

Phenylalanine, C-C skeletal

(Su, Ho et
al. 2006)

1031

d(C-H), phenylalanine (protein
assignment)

(Huang,
McWilliams
et al. 2003)

1045

(symmetric stretching vibration of
PO4

(Cheng, Liu
et al. 2005)

1059

Lipids

(Dukor
2002)

1077

PO2 RNA

(Huang,
McWilliams
et al. 2003)

1089

Phospholipids

(Huang,
McWilliams
et al. 2003)

1157

In-plane vibrations of the conjugated
C=C-C

(Puppels,
Garritsen et
al. 1993)

1175

C-H bending, tyrosine

(Ruiz‐Chica
, Medina et
al. 2004)

Amide III (proteins)

(Notingher,
Green et al.
2004)

1214

Stretching of C-N

(Naumann
1998)

1222

(PO2), nucleic acids

(Huang,
McWilliams
et al. 2003)

CH3CH2 wagging mode of collagen

(Stone,
Kendall et
al. 2004)

Guanine

(Ruiz‐Chica
, Medina et

1200-50

1311-1361

1319

al. 2004)
1322

CH3CH2 twisting

(Huang,
McWilliams
et al. 2003)

1344

CH stretching

(Farquharso
n, Shende et
al. 2005)

1355

Guanine

(Ruiz‐Chica
, Medina et
al. 2004)

1390

CH rocking

(Schulz and
Baranska
2007)

1424

Deoxyribose

(Ruiz‐Chica
, Medina et
al. 2004)

1440

CH2 and CH3 deformation vibrations

(Hanlon,
Manoharan
et al. 2000)

1465

Lipids

(Lakshmi,
Kartha et al.
2002)

Amide II

(Dukor
2002)

1484

G, A (ring breathing modes in the
DNA bases)

(Chan,
Taylor et al.
2006)

1489

DNA

(Malini,
Venkatakris
hna et al.
2006)

1502

C=C stretching in benzenoid ring

(Naumann

1481-1562

1998)
1522

C=C- carotenoid

(Stone,
Kendall et
al. 2004)

1537

Amide carbonyl group vibrations

(Wood,
Quinn et al.
1998)

1578

Guanine (N3)

(Ruiz‐Chica
, Medina et
al. 2004)

1602

Amide I band of proteins

(Sigurdsson,
Philipsen et
al. 2004;
Chan,
Taylor et al.
2006)

1620

n(C=C), tryptophan (protein
assignment)

(Huang,
McWilliams
et al. 2003)

1641

Amide I (alpha-helix)

(Stone,
Kendall et
al. 2004)

1676

Amide I (beta-sheet)

(Lakshmi,
Kartha et al.
2002).

1678

C=O stretching mode of dGTP of
RNA

(D'Amico,
Cammisuli
et al. 2015)

1708

n(C=O)OH (amino acids aspartic &
glutamic
acid)

(Shetty,
Kendall et
al. 2006)

1721

C=O stretching/proteins

(Movasaghi,
Rehman et

al. 2007)
1729

Ester group

(Krafft,
Neudert et
al. 2005)

1738

Lipids

(Dukor
2002)

1749

C=O stretching

(Malini,
Venkatakris
hna et al.
2006)

1765

C=O sym stretch; part of doublet

(Schrader
2008)

1778

C=O stretch

(Schrader
2008)

1783

C=O stretch

(Schrader
2008)

Table 2: Peak assignments of the Raman spectral features.

Results:
Figure 1 shows the mean Raman spectra of samples of healthy (a) and HCV positive blood
plasma samples with low (b), medium (c) and high (d) viral load values. The Raman spectral
features present in mean Raman spectra of blood plasma samples of healthy individuals (a)
include those assigned to proteins, at 651 cm-1(C-S stretching of amino acid), 674 cm-1(C-S
stretching), 727 cm-1(C-C stretching), 737-773 cm-1(C-S stretching, tryptophan), 1311-1361 cm-1
(amide, tryptophan), 880 cm-1(tryptophan ring), 934 cm-1(C-C backbone of proteins /alpha helix
stretching), 1175cm-1(C-H bending, tyrosine), 1481-1562 cm-1(Amide II), 1602 cm1

(phenylalanine), 1641 cm-1(amide-I). Moreover, other Raman features present in healthy spectra

can be assigned to lipids, including those at 958 cm-1 (C-C stretching of lipids), 1059 cm-1 (C-C

str./lipids), 1390 (C-N rocking), 1620 cm-1 (C-C stretching), 1729 cm-1 (ester group) and 1738
cm-1 (C=O of ester group in lipids). Notably, no Raman features associated with DNA/RNA are
evident in the healthy blood plasma samples.
To highlight the changes in the mean Raman spectra of HCV positive samples, he peak
assignments have been labelled in Figures 1 (b-c) with; red boxes for prominent and striking
differences in different viral load values, rectangles for intensity changes and vertical lines for
other differences.
The peak intensities of the above mentioned protein and lipids related peaks are increasing in (b),
(c) and (d) with increase in degree of infection. Now, the most striking differences, observed in
the mean Raman spectra, are the Raman spectral features which are solely observed for the HCV
positive samples including those at 720 cm-1 (adenine), 1077 cm-1 (PO2 stretching of RNA), 1678
cm-1(C=O stretching mode of dGTP of RNA), 1778 cm-1 (RNA), 1641 (amide-I), 1721 cm1

(C=C stretching of proteins)and 1738 cm-1 (C=O of ester group in lipids). These Raman features

are potentially spectral markers for the presence of infection of HCV in the blood plasma
samples.

c

Figure 1:Mean Raman spectra of healthy and HCV positive blood plasma samples with
increasing viral load values; healthy (a), low viral load (b), medium viral load (c) and high viral
load (d) as described in Table 1.(Vertical lines with red box are for striking differences ,without
red box are showing intensity changes and doted box for bands and pattern change).

In Figure 2, mean difference spectra, healthy minus HCV positive blood plasma samples, of
different viral load values which, for the purpose of comparison (Table-1), are divided into three
classes including low (a), medium (b) and high (c), are shown. In the mean difference spectra,
the differences in Raman spectral features associated with 3 different ranges of infection levels
of HCV have been observed, and labeled. The difference spectra confirm the observations of
Figure 1,as the Raman spectral features which feature prominently in the HCV positive samples,

including those at720 cm-1 (adenine), and 1077 cm-1 (PO2 stretching of RNA), 1678 C=O
stretching mode of dGTP of RNA, 1778 cm-1 (RNA), 1641 (amide-I), 1721 cm-1(C=C stretching
of proteins)and 1738 cm-1 (C=O of ester group in lipids), appear only in the HCV positive
samples and hence maybe attributable to RNA stretching of the hepatitis C virus itself. These
spectral features can be considered as direct markers of the viral infection in addition to those
which are associated with the development of the biochemical changes during HCV infection.
Clear differences in peak intensities at 616 (C-C twisting of proteins), 630 (C-S of amino acid
methionine), 751 (symmetric breathing of tryptophan), 857 (Tyrosine), 951 (CH stretching of
protein alpha-helix), 1031, 1045, 1214 (stretching of C-N), 1440 (CH2 and CH3 deformation),
1465 (CH stretching of lipids), 1484 (G, A/RNA bases), 1522 (C=C- carotenoid), 1708 and 1765
(C=O of amino acids), and 1783 cm-1 are observed. These differences indicate the progression of
the HCV infection from low to medium and high viral loads

Figure 2: Mean difference Raman spectra of three classes of HCV samples including low (a),
medium (b) and high (c) viral loads as described in Table-1. Spectra are off-set for clarity.

Figure 3 PCA scatter plots of Raman spectral data of different categories of HCV samples
according to viral load values including low versus medium (a), medium versus high (b) and
their respective PCA loadings.

In Figure 3 (a, b and c) PCA scatter plots and loadings of Raman spectral data of different
categories of HCV samples according to viral load values including low (HCV-2), medium
(HCV-5 and HCV-7) and high (HCV-11), as detailed in Table-1, are presented. The separation
between the Raman spectra of HCV confirmed blood plasma samples of different categories of
HCV samples according to viral load values is observed along PC-1.The Raman spectral features

which are on the positive side are associated with low to high viral loads. In this regard, those
Raman spectral features which have higher intensities with the severity of disease include those
at720 cm-1 (adenine), 1077 cm-1 (PO2 stretching of RNA), 1678 C=O stretching mode of dGTP
of RNA, 1778 cm-1 (RNA), 1641 (amide-I), 1721 cm-1(C=C stretching of proteins)and 1738 cm-1
(C=O of ester group in lipids.

Principal components analysis (PCA) was performed on the Raman spectral data of the ten
controls/ healthy and eleven confirmed HCV samples, having different viral load values. In the
PCA scatter plot, Figure 4 (a), the blue and red dots represent Raman spectra of HCV positive
and healthy blood plasma samples, respectively, which are largely clustered on the positive and
negative sides of PC-1 respectively, which accounts for 79% of the variance, while PC-2
accounts for only 7 %. The differentiation between these two different groups of Raman spectra
supports the proposal that Raman spectroscopy has great potential to differentiate the blood
plasma samples of the healthy and HCV positive individuals on the basis of the biochemical
changes with reference to their viral load values of HCV.
To understand the basis of the discrimination in the PCA scatter plot, the loadings of PC-1 are
presented in Figure 4 (b).The positive loadings (positive side from separating line at zero) are
associated with the Raman spectral data of the HCV positive samples while the negative loadings
are associated with the healthy samples. Notably, (in Figure 4) the PCA loadings including those
at 674 cm-1, associated with the T/G of RNA,720 cm-1 (adenine) and 1077 cm-1 (PO2 stretching
of RNA),1678 cm-1 C=O stretching mode of dGTP of RNA, 1778 cm-1 (RNA), 1641 (amide-I),
1721 cm-1(C=C stretching of proteins)and 1738 cm-1 (C=O of ester group in lipids) are associated
with the HCV positive samples. These observations once again confirm the results explained in
the previous Figures and prove the ability of the Raman spectroscopy to identify the biochemical
changes taking place during HCV infection. The observation of these Raman features as positive
loadings indicate their association with the HCV RNA hence to the development of the HCV
infection due to increasing viral load. Moreover, some other Raman spectral features/changes are
also observed with a reduction in the their peak intensity or are not present in the control/healthy
samples and are well developed in positive blood plasma samples indicated by the wave numbers
including 880cm-1( associated with tryptophan), 1089cm-1 (C-C stretching), 1390cm-1 (C-N

rocking),
1

1502cm-1(cytosine),1641cm-1(Amide-I),1728cm-1

(ester)

and

1738cm-

(lipids)(Movasaghi, Rehman et al. 2007). Furthermore, in comparison of loading with

experimental Raman spectrum of pure RNA some peaks are observed which are similar in
loadings of HCV samples including 720cm-1, 813cm-1, 880cm-1, 922cm-1, 1105cm-1, 1489cm-1,
and 1578cm-1. These Raman spectral features observed in the Figure 4indicate that all these
biochemical changes/Raman spectral features can be considered as markers of HCV infection as
they are also present in experimental Raman spectra of pure RNA and absent in the
healthy/control Raman spectra.

Figure 4 PCA scatter plot (a) and loadings of Raman spectral data acquired from healthy versus
confirm HCV samples (b).

Conclusions
In order to identify the biochemical changes occurring during the process of Hepatitis C
development, Raman spectroscopy along with Principal Component analysis is employed.
Raman spectral features as indicated by Principal Component analysis are hence established
which can be associated with the human blood plasma samples of the infected and healthy
individuals. Among others, the Raman spectral features which are observed only for the HCV
positive samples include 720 cm-1 (adenine), 1077 cm-1 (PO2 stretching of RNA), 1678 C=O
stretching mode of dGTP of RNA, 1778 cm-1 (RNA), 1641 (amide-I), 1721 cm-1(C=C stretching
of proteins)and 1738 cm-1 (C=O of ester group in lipids). These differences in Raman spectral
features of blood plasma samples of the patients and healthy volunteers can be associated with
the development of the biochemical changes during HCV infection.
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